1. Home
  2. CANF vs MITQ Comparison

CANF vs MITQ Comparison

Compare CANF & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

N/A

Current Price

$1.44

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

Logo Moving iMage Technologies Inc.

MITQ

Moving iMage Technologies Inc.

N/A

Current Price

$0.53

Market Cap

5.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
CANF
MITQ
Founded
1994
N/A
Country
Israel
United States
Employees
N/A
25
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.0M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
CANF
MITQ
Price
$1.44
$0.53
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $7.50
N/A
AVG Volume (30 Days)
★ 27.0K
19.7K
Earning Date
09-08-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 70.00
EPS
★ N/A
N/A
Revenue
N/A
★ $20,139,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.17
$0.42
52 Week High
$10.40
$0.82

Technical Indicators

Market Signals
Indicator
CANF
MITQ
Relative Strength Index (RSI) 24.58 58.97
Support Level N/A $0.54
Resistance Level $3.59 $0.57
Average True Range (ATR) 0.10 0.03
MACD 0.00 0.01
Stochastic Oscillator 6.90 80.52

Price Performance

Historical Comparison
CANF
MITQ

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management. It provides products, integrated systems design, custom engineering, proprietary products, software, and installation services for cinemas, screening rooms, postproduction facilities, high-end home theaters, stadiums, and other entertainment spaces. It also distributes and integrates cinema equipment from Barco, Sharp (NEC) Digital Cinema, Christie Digital, LEA Professional, Dolby, GDC, JBL/Crown, and Others.

Share on Social Networks: